SIGMA G9885-25MG α1 -酸性糖蛋白 来源于人类血浆

属性
生物来源
human plasma

质量水平
200

检测方案
≥99% (agarose gel electrophoresis)

形式
powder

technique(s)
ELISA: suitable

杂质
HIV-1/HIV-2, HCV and hepatitis B antigen, tested negative

UniProt登记号
P02763

储存温度
2-8°C

Gene Information

human … ORM1(5004)

说明
一般描述
α-1-酸性糖蛋白(AGP)/血清类粘蛋白(ORM),一种糖蛋白,分子量为 41-43kDa。它被认为是人和大鼠中重要的急性期蛋白之一。AGP 可能属于脂质运载蛋白家族。[1]
应用
α人血浆中的 1-酸性糖蛋白已用于:
作为带负电荷的蛋白,以研究在聚电解质多层表面上的吸附过程[2]
在研究中孵育涂有纯化抗血清的平板,以通过 ELISA 研究其血清浓度[3]
研究不同浓度对人免疫缺陷病毒(HIV)蛋白酶抑制剂的抗病毒活性的影响[4]

生化/生理作用
α1-酸性糖蛋白具有免疫调节作用。它能结合酸性药物(例如苯巴比妥)。[1]
制备说明
从科恩级分 VI 纯化

SIGMA G9885-5MG α1 -酸性糖蛋白 来源于人类血浆

属性
生物来源
human plasma

质量水平
200

检测方案
≥99% (agarose gel electrophoresis)

形式
powder

technique(s)
ELISA: suitable

杂质
HIV-1/HIV-2, HCV and hepatitis B antigen, tested negative

UniProt登记号
P02763

储存温度
2-8°C

Gene Information

human … ORM1(5004)

说明
一般描述
α-1-酸性糖蛋白(AGP)/血清类粘蛋白(ORM),一种糖蛋白,分子量为 41-43kDa。它被认为是人和大鼠中重要的急性期蛋白之一。AGP 可能属于脂质运载蛋白家族。[1]
应用
α人血浆中的 1-酸性糖蛋白已用于:
作为带负电荷的蛋白,以研究在聚电解质多层表面上的吸附过程[2]
在研究中孵育涂有纯化抗血清的平板,以通过 ELISA 研究其血清浓度[3]
研究不同浓度对人免疫缺陷病毒(HIV)蛋白酶抑制剂的抗病毒活性的影响[4]

生化/生理作用
α1-酸性糖蛋白具有免疫调节作用。它能结合酸性药物(例如苯巴比妥)。[1]
制备说明
从科恩级分 VI 纯化

SIGMA MAB1217-I Anti-Fmc-7 (B-Cell Lymphocyte Marker), clone Fmc-7 Antibody

属性
生物来源
mouse

质量水平
100

抗体形式
purified immunoglobulin

antibody product type
primary antibodies

克隆
Fmc-7, monoclonal

species reactivity
human

technique(s)
flow cytometry: suitable
western blot: suitable

同位素/亚型
IgMκ

运输
wet ice

Gene Information

human … MS4A1(931)

说明
一般描述
B cells are lymphocytes that play a large role in the humoral immune response as opposed to the cell-mediated immune response that is governed by T cells. The principal function of B cells is to make antibodies against soluble antigens. B cells are an essential component of the adaptive immune system. FMC-7 B-Cell Lymphocyte Marker is a 105 kDa B cell restricted antigen which is expressed on about 50% of adult human peripheral blood B cells. Upon in vivo B cell activation FMC7 expression initially increases. B cells involved in antibody secretion have lost the FMC7 determinant. The monoclonal antibody FMC7 delineates a subpopulation of B lymphocytes in normal blood. Expression of the antigen recognized by FMC7 appears to be maturation-linked, and it serves to distinguish different types of B cell leukemia.
免疫原
HRIK [human B-lymphoblastoid cell] corresponding to human Fmc-7 (B-Cell Lymphocyte Marker).
应用
Flow Cytometry Analysis: 4.0 μg of this antibody detected Fmc-7 (B-Cell Lymphocyte Marker) in peripheral blood mononuclear cells.
This Anti-Fmc-7 (B-Cell Lymphocyte Marker) antibody is validated for use in WB, FC for the detection of Fmc-7 (B-Cell Lymphocyte Marker).
质量
Evaluated by Western Blotting in THP-1 cell lysate.

Western Blotting Analysis: 2.0 μg/mL of this antibody detected Fmc-7 (B-Cell Lymphocyte Marker) in 10 μg of THP-1 cell lysate.
目标描述
~105 kDa observed. Uncharacterized band(s) may appear in some lysates.
外形
Ammonium Sulfate
Format: Purified
Purified mouse monoclonal IgMκ in buffer containing 0.1M Tris, 10mM Glycine, 0.5M NaCl, and 0.1% Sodium Azide.
其他说明
Concentration: Please refer to lot specific datasheet.
免责声明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

SIGMA A9731-1G 白蛋白 人

属性

生物来源

human

质量水平

200

重组

expressed in rice

检测方案

≥96% (SDS-PAGE)

形式

lyophilized powder

分子量

monomer ~67kDa

technique(s)

cell culture | mammalian: suitable

杂质

≤1EU/mg protein

UniProt登记号

P02768

储存温度

2-8°C

InChI

1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11

InChI key

QYSGYZVSCZSLHT-UHFFFAOYSA-N

Gene Information

human …ALB(213)

说明

应用

该重组变异建议用于:吸收、分散、代谢和排泄(ADME)药理学研究;细胞培养;药物递送研究;细胞冻存。

生化/生理作用

白蛋白是可见于动物体液和组织及部分植物种子的一类可溶性单体蛋白。 血清白蛋白可作为类固醇、脂肪酸和甲状腺激素的载体蛋白。 血清白蛋白在调节血液的胶体渗透压方面也至关重要。

特点和优势

Cellastim是一种性质明确、无动物源成分的重组型人白蛋白(rHA)。 Cellastim专为细胞培养应用而设计,是一种性能优于血浆来源的人白蛋白、牛血清白蛋白和其他来源的重组人白蛋白的强大培养基补充剂。Cellastim带来的是稳定一致的性能,而不是与水解产物和提取物相关的变量。Cellastim是适用于中国仓鼠卵巢(CHO)、杂交瘤、VERO、干细胞和原代细胞培养基的理想选择。

优势

消除了动物来源的添加剂

安全且符合监管要求

证明在胚胎、间充质、神经、心脏、肝脏、肾脏、角质形成细胞和成纤维干细胞系中可有效增强干细胞的生长

维持干细胞处在未分化状态

消除了贴壁细胞系培养板的涂层

提供性质明确且稳定一致的干细胞培养基

SIGMA SAB4200791-1VL Anti-Human IgG (Fab specific)-Peroxidase antibody, Mouse monoclonal

属性
生物来源
mouse

质量水平
200

偶联物
peroxidase conjugate

抗体形式
purified from hybridoma cell culture

antibody product type
primary antibodies

克隆
GG-6, monoclonal

形式
lyophilized powder

species reactivity
human

浓度
~2 mg/mL

technique(s)
direct ELISA: 1:16,000-1:32,000 using 2.5 μg/ml human IgG for coating.

同位素/亚型
IgG1

运输
dry ice

储存温度
20°C

target post-translational modification

unmodified

说明
一般描述
Anti-Human IgG (Fab specific)-Peroxidase antibody, Mouse monoclonal (mouse IgG1 isotype) is derived from the GG-6 hybridoma, produced by the fusion of mouse myeloma cells and splenocytes from mouse immunized with purified human IgG (Fab fragment). IgGs are the most common Immunoglobulins isotype in blood, lymph fluid, cerebrospinal fluid and peritoneal fluid and a key players in the humoral immune response. IgGs include four subclasses (IgG1, IgG2, IgG3, and IgG4), they consist of a variable Fab fragment (which includes the antibody recognition site), and a conserved Fc fragment. The IgG subclasses differ in their physical and chemical properties, their distribution pattern is found to be age-dependent, and every subclass has a specific biological function.
Anti-Human IgG (Fab specific)-Peroxidase antibody, Mouse monoclonal (mouse IgG1 isotype) is derived from the GG-6 hybridoma, produced by the fusion of mouse myeloma cells and splenocytes from mouse immunized with purified human IgG.
免疫原
Purified human IgG (Fab Fragment)
应用
Direct ELISA: a working dilution of 1:16,000-1:32,000 is recommended using 2.5 μg/mL human IgG for coating.
生化/生理作用
Immunoglobulin G (IgG) participates in hypersensitivity type II and type III reactions. Maternal IgG is the only antibody transported across the placenta to the fetus. Maternal IgG passively immunizes the infants. IgG deficiencies are often associated with various diseases.
外形
Supplied as a lyophilized powder.
其他说明
In order to obtain best results in different techniques and preparations we recommend determining optimal working concentration by titration test.

SIGMA C8571-25UG 组织蛋白酶B 来源于人类肝脏

属性
生物来源
human liver

质量水平
200

形式
buffered aqueous solution

specific activity
≥1,500 units/mg protein (E1%/280)

UniProt登记号
P07858

运输
dry ice

储存温度
70°C

Gene Information

human … CTSB(1508)

说明
一般描述
组织蛋白酶B基因映射至人类染色体8p23.1。[1]它是一种溶酶体半胱氨酸,252个氨基酸分布在两条链上,与大鼠肝脏序列对应。[2]它具有盘状结构,分为两个域,即氨基末端的左侧′L′域和羧基末端的右侧′R′域。[3]
应用
来自人体肝脏的组织蛋白酶B已被用于以下情形:
在筛选组织蛋白酶B抑制剂试验中用作阳性对照物[4]
细胞壁伸展(扩张蛋白活性)试验[5]
显微注射人包皮成纤维细胞,测试诱导凋亡效果[6]

生化/生理作用
已经发现组织蛋白酶B切割前痉挛1和前痉挛11,并诱导洋地黄皂苷通透的细胞凋亡。组织蛋白酶B从细胞质向细胞核的转移有助于胆盐诱导大鼠肝细胞凋亡。诱导细胞凋亡后12-24小时,PC12细胞组织蛋白酶B水平显著下降。
来自人体肝脏的组织蛋白酶B在食管腺癌(EAC)中高度表达。[1]它可以减少肝脏炎症和纤维化,对治疗肝脏疾病具有潜在效果。[7]
包装
包装规格取决于蛋白质含量
单位定义
在40℃条件下,当pH为6.0时,一个单位每分钟将从Z-Arg-Arg 7-氨基-4-甲基香豆素中释放1纳米摩尔的7-氨基-4-甲基香豆素。
外形
50 mM醋酸钠溶液,pH 5.0,含1 mM EDTA。

bioGenous人小肠 Human Intestinal Organoid Kit(K2002-HI)

人小肠 Human Intestinal Organoid Kit

货号:K2002-HI

规格:100ml

500ml

品牌:bioGenous

产品介绍

Product Description:

bioGenousTM Human Intestinal Organoid Kit is a chemically defined cell culture medium for establishment and maintenance of human intestinal organoids(hIOs) derived from adult stem cells. Self-renewal of the intestinal epithelium is driven by the proliferation of stem cells and their progenitors located in crypts. Human intestinal organoids display all hallmarks of the intestinal epithelium in terms of architecture, cell type composition, and self-renewal dynamics, therefore hold great promise for unprecedented studies of human intestinal development and disease, human intestinal organoids may also have applications in regenerative biology through ex vivo expansion of the intestinal epithelium.


技术参数

Product Information:

Component

Component Cat#

Volume

Storage& Stability

bioGenousTM Human Intestinal Organoid Basal Medium

K2002-HI-A100/A500

100mL/500 mL

412 months

bioGenousTM Human Intestinal Organoid Supplement B(50x)

K2002-HI-B100/B500

2mL/10 mL

-20,avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Intestinal Organoid Supplement C(250x)

K2002-HI-C100/C500

0.4mL/2 mL

-20, avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Intestinal Organoid Supplement D(250x)

K2002-HI-D100/D500

0.1mL/0.5 mL

-20, avoid repeated freeze-thaw cycles, 12 months

Preparation of Human Intestinal Organoid Expansion Medium and Maintenance Medium

Use sterile technique to prepare the human intestinal organoid expansion medium and maintenance medium. hIOs grown in Human Intestinal Organoid Expansion Medium overwhelmingly consisted of LGR5+ stem cells, cycling transit amplifying (TA) cells, early enterocytes and a small number of goblet cells. Organoids grown in Human Intestinal Organoid Maintenance Medium contain LGR5+ stem cells, TA cells, early and mature enterocytes, goblet cells, M cells and enteroendocrine cells, as well as a low number of Paneth cells and tuft cells. The following examples are for preparing 10 mL of Expansion Medium and Maintenance Medium. If preparing other volumes, adjust accordingly.

1.       Thaw Human Intestinal Organoid Supplement B(50x), Human Intestinal Organoid Supplement C(250x) and Human Intestinal Organoid Supplement D(250x) on ice. Mix thoroughly.

NOTE: Once thawed, use immediately or aliquot and store at -20°C for not more than 10 months. After thawing the aliquots, use immediately. Do not re-freeze.

2.       For Human Intestinal Organoid Expansion Medium. Add 200 μL Human Intestinal Organoid Supplement B(50x), 40 μL Human Intestinal Organoid Supplement C(250x) and 40 μL Human Intestinal Organoid Supplement D(250x) to 9.72 mL Human Intestinal Organoid Basal Medium. Mix thoroughly.

3.       For Human Intestinal Organoid Maintenance Medium. Add 200 μL Human Intestinal Organoid Supplement B(50x) and 40 μL Human Intestinal Organoid Supplement C(250x) to 9.76 mL Human Intestinal Organoid Basal Medium. Mix thoroughly.

NOTE: If not use immediately, store complete medium at 2-8°C for not more than 2 weeks. bioGenousTM Human Intestinal Organoid Supplement B contains fungicide and antibiotics(50x).

 

Protocol for Establishment of Human Intestinal Organoids

CAUTIONStudies involving primary human tissue material must follow all relevant institutional and governmental regulations. Informed consent must be obtained from all subjects before the collection of the primary human tissue material.

Establishment of Organoids from Primary Tissue

1.       Collect primary human intestinal tissue pieces in ice-cold Primary Tissue Storage Solution (K601005) with conical tubes. Keep tissue samples at 4°C until the start of the isolation.

2.       Assess whether the obtained tissue pieces consist purely of epithelium or if they also contain fat or muscle tissue. If so, remove non-epithelial components as much as possible using surgical scissors or scalpels and forceps under a dissection microscope. If no fat or muscle tissue are present, continue to the next step immediately.

3.       Rinse the intestinal tissue with Epithelial Organoid Basal Medium(B213151) or DPBS until the supernatant is clear.

4.       Before crypt isolation, thaw Matrigel on ice and keep it cold. Add 5 mL of FBS to 45 mL of Epithelial Organoid Basal Medium to prepare 10% (vol/vol) FBS medium.

5.       Mince the tissue into small fragments of 5 mm3 in a cell culture dish using surgical scissors or scalpels.

CRITICAL The dissected samples must be small enough to pass through the tip of a 10 mL pipette.

6.       Place the dissected pieces of sample into a 15 mL conical tube containing 10 mL of cold DPBS.

7.       Wash the samples by pipetting with a 10 mL pipette at least ten times.

CRITICAL For the subsequent steps, coat the inner surface of every 10 mL pipette with 10% (vol/vol) FBS medium before use to avoid adherence of the samples on the pipette wall.

8.       Stand the tube still until the samples settle at the bottom. Aspirate the supernatant with a 10 mL pipette and add 10 mL of cold DPBS.

9.       Repeat Steps 7 and 8 3–5 times until the supernatant is free of debris.

CRITICAL Thorough washing of the sample is crucial to avoid bacterial contamination.

10.    Add 10 mL of cold DPBS supplemented with 2.5 mM EDTA (E219121) to the tube. Place the tube on a rocking shaker and rock it gently at 4 °C for 40 min.

11.    After treatment with EDTA, stand the tube still until the samples settle to the bottom of the tube, and then aspirate the supernatant with a 10 mL pipette and add 10 mL of cold DPBS.

12.    Stand the tube still until the samples settle at the bottom. Aspirate the supernatant with a 10 mL pipette.

13.    Add 10 mL of cold DPBS and pipette up and down at least ten times with a 10 mL pipette. Allowed the tissue fragments to settle down under normal gravity for at least 30s. The crypts will be released into the supernatant by pipetting. Place the supernatant containing the isolated crypts into a new 15 mL tube.

14.    Spin the crypts at 4°C at 400g for 3 min. Remove the supernatant and place the tube on ice.

15.    Resuspend the pellet in 1 mL of DPBS and transfer the crypt suspension into a new 1.5 mL tube. Drop 20 μL of the crypt suspension on a petri dish. Count the number of crypts under a stereomicroscope and calculate the total number of crypts.

16.    Spin the crypts at 4°C at 400g for 3 min. Aspirate and discard the supernatant.

17.    Aspirate the supernatant and resuspend the pellet in Matrigel. Matrigel should be kept on ice to prevent it from solidifying; thus, work quickly. The amount of Matrigel depends on the size of the pellet. Approximately 50-250 crypts should be plated in 25 μL of Matrigel.

CRITICAL Do not dilute Matrigel too much (Matrigel should be >70% (Matrigel vol/Total vol)) to ensure formation of solid droplets.

18.    Plate the Matrigel containing organoids on the bottom of 24-well cell culture plates in droplets of ~30 μL each around the center of the well.

CRITICALOnce the organoids are resuspended in Matrigel, proceed with plating as quickly as possible, as the Matrigel may solidify in the tube or pipette tip. Do not let the Matrigel touch the wall of wells.

19.    Place the culture plate into a humidified incubator at 37 °C and 5% (vol/vol) CO2 for 15-25 min to let the Matrigel solidify.

20.    Prepare the required amount of bioGenousTM Human Intestinal Organoid Expansion Medium.

21.    Once the Matrigel droplets are solidified (15-25 min), open the plate and carefully add 500 μL of Organoid Complete Medium to each well.

CRITICAL Do not add the medium directly on top of the Matrigel droplets, as this might disrupt the droplets.

22.    Place the culture plate in a humidified incubator at 37 °C and 5% (vol/vol) CO2.

23.    Change the medium every 3 days by carefully aspirating medium from the wells and replacing it with fresh, pre-warmed Organoid Complete Medium.

24.    Closely monitor the organoid formation. Ideally, human intestinal organoids should be passaged for the first time between 5 and 8 days after initial plating.

Splitting and Passaging of Organoids

25.    Pipette up and down to disrupt the Matrigel, and transfer the organoid suspension into a 1.5 mL conical tube.

26.    Pipette the organoid suspension up and down to mix thoroughly.Use the bottom of the tube to create pressure, which will aid the removal of Matrigel.

27.    Centrifuge organoids at 200g for 3 min at room temperature.

28.    Aspirate the supernatant, and split organoids using either mechanical disruption or Organoid Dissociation Solution (E238001). For mechanical disruption, resuspend the pellet in 1 mL of Organoid Basal Medium. Use a pipette tip to pipette the organoid suspension up and down 30 times. Use the bottom of the tube to create pressure, which will aid organoid disruption. In case of Organoid Dissociation Solution-based cell dissociation, resuspend the pellet in 0.2 mL of Organoid Dissociation Solution, pipette up and down and incubate at 37 °C until organoids fall apart. Pipette up and down with a filter tip for ≥10 times every 1 min to aid in the disruption of the organoids. Monitor digestion closely to keep the incubation time in Organoid Dissociation Solution to a minimum.

CRITICAL Do not dissociate in Organoid Dissociation Solution for >3 min, as this may result in poor organoid outgrowth or even loss of the culture. As a rule of thumb, digestion is complete if a mixture of small lumps of cells (consisting of 10–50 cells) can be observed.

29.    After shearing is complete, wash once by topping up with 1 mL ofOrganoid Basal Medium, and centrifuge at 200g for 3 min at room temperature.

30.    Aspirate the supernatant and resuspend the organoid pellet in 70% (vol/vol) Matrigel, and plate organoids in droplets on the bottom of a culture plate as described in Steps 12. After plating is complete, transfer the plate into a humidified incubator at 37 °C and 5% (vol/vol) CO2 for 15–25 min.

31.    Pre-warm Human Intestinal Organoid Maintenance Medium at 37 °C.

32.    After the Matrigel droplets have solidified (15–25 min), carefully pipette pre-warmed medium into the wells.

33.    Place culture plates in a humidified incubator at 37 °C and 5% (vol/vol) CO2 until the organoids are needed for further experiments.

bioGenous人胆管类器官分化试剂盒 Human Liver Ductal Organoid Kit (Differentiation)(K2008-HLH)

人胆管类器官分化试剂盒 Human Liver Ductal Organoid Kit (Differentiation)

货号:K2008-HLH

规格:100ml

500ml

品牌:bioGenous

产品介绍

Product Description:

bioGenousTM Human Liver Ductal Organoid Kit is a chemically defined cell culture medium for establishment and maintenance of human liver ductal organoids(hLDs) derived from adult stem cells. Self-renewal of the liver ductal epithelium is driven by the proliferation of stem cells and their progenitors located in liver. hLDs display all hallmarks of the liver ductal epithelium in terms of architecture, cell type composition, and self-renewal dynamics, therefore hold great promise for unprecedented studies of Human liver development and disease, hLDs could differentiate into hepatocyte like cell under the induction of differentiation medium.


技术参数

Product Information:

Component

Component Cat#

Volume

Storage& Stability

bioGenousTM Human Liver Ductal Organoid Basal MediumDifferentiation

K2008-HLH –A100/A500

100mL/500mL

4℃,12 months

bioGenousTM Human Liver Ductal Organoid Supplement B(50x)Differentiation

K2008-HLH –B100/B500

2mL/10mL

-20,avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Liver Ductal Organoid Supplement C(250x) Differentiation

K2008-HLH –C100/C500

0.4mL/2mL

-20, avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Liver Ductal Organoid Supplement D(250x) Differentiation

K2008-HLH –D100/D500

0.4mL/2mL

-20, avoid repeated freeze-thaw cycles, 12 months

Preparation of Human Liver Ductal Organoid Differentiation Medium

Use sterile technique to prepare the human liver ductal organoid differentiation medium. hLDs grown in Human Liver Ductal Organoid Expansion Medium overwhelmingly consisted of cholangiocytes. After changing the Expansion Medium to differentiation medium, the hLDs could differentiate into hepatocyte like cells, which display the markers of hepatocytes, including ALBUMINTTR and CYP3A4. The following examples are for preparing 10 mL of Differentiation I Medium and Differentiation II Medium. If preparing other volumes, adjust accordingly.

1.       Thaw Human Liver Ductal Organoid Supplement B(50x) (Differentiation), Human Liver Ductal Organoid Supplement C(250x) (Differentiation) and Human Liver Ductal Organoid Supplement D(250x) (Differentiation) on ice.

NOTE: Once thawed, use immediately or aliquot and store at -20°C for not more than 10 months. After thawing the aliquots, use immediately. Do not re-freeze.

2.       For Human Liver Ductal Organoid Differentiation Medium I. Add 40 μL Human Liver Ductal Organoid Supplement D(250x) (Differentiation) to 10 mL Human Liver Ductal Organoid Medium(Expansion) (K2008-HLD). Mix thoroughly.

3.       For Human Liver Ductal Organoid Differentiation Medium II. Add 200 μL Human Liver Ductal Organoid Supplement B(50x) (Differentiation) and 40 μL Human Liver Ductal Organoid Supplement C(250x)Differentiationto 10 mL Human Liver Ductal Organoid Basal Medium (Differentiation). Mix thoroughly.

NOTE: If not use immediately, store complete medium at 2-8°C for not more than 2 weeks. bioGenousTM Human Liver Ductal Organoid Supplement B (Differentiation) contains fungicide and antibiotics(50x).

 

Protocol for Human Liver Ductal Organoids Differentiation

1.     Culture the human liver ductal organoids in differentiation medium I after seeding for 5 days.

2.     Change the medium to Human Liver Ductal Organoid Differentiation Medium II, and culture for 10 days. During this period, replace the medium every 3 days.

At the end of this period, the differentiation process is completed. The liver ductal organoid would differentiate into hepatocyte-like organoid with the expression of hepatic markers, such as ALBUMIN, TTR, CYP3A4 and MRP2.

bioGenous人胆管类器官 Human Liver Ductal Organoid Kit (Expansion)(K2008-HLD)

人胆管类器官 Human Liver Ductal Organoid Kit (Expansion)

货号:K2008-HLD

规格:100ml

500ml

品牌:bioGenous


产品介绍

Product Description:

bioGenousTM Human Liver Ductal Organoid Kit is a chemically defined cell culture medium for establishment and maintenance of human liver ductal organoids(hLDs) derived from introhepatic cholangiocyte. Self-renewal of the ductal epithelium is driven by the proliferation of stem cells and their progenitors located in liver. hLDs display all hallmarks of the ductal epithelium in terms of architecture, cell type composition, and self-renewal dynamics, therefore hold great promise for unprecedented studies of human liver development and disease, hLDs may also have applications in regenerative biology through ex vivo expansion of the ductal epithelium.


技术参数

Product Information:

Component

Component Cat#

Volume

Storage& Stability

bioGenousTM Human Liver Ductal Organoid Basal Medium(expansion)

K2008-HLD –A100/A500

100mL/500mL

412 months

bioGenousTM Human Liver Ductal Organoid Supplement B(50x) (expansion)

K2008-HLD –B100/B500

2mL/10mL

-20,avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Liver Ductal Organoid Supplement C(250x) (expansion)

K2008-HLD–C100/C500

0.4mL/2mL

-20, avoid repeated freeze-thaw cycles, 12 months

Preparation of Human Liver Ductal Organoid Expansion Medium and Maintenance Medium

Use a sterile technique to prepare the human liver ductal organoid expansion medium and maintenance medium. hLDs grown in Human Liver Ductal Organoid Expansion Medium overwhelmingly consisted of cholangiocytes. The following example is for preparing 10 mL Expansion Medium and Maintenance Medium. If preparing other volumes, adjust accordingly.

1.       Thaw Human Liver Ductal Organoid Supplement B(50x) (Expansion), Human Liver Ductal Organoid Supplement C(250x) (Expansion)on ice. Mix thoroughly.

NOTE: Once thawed, use immediately or aliquot and store at -20°C for not more than 10 months. After thawing the aliquots, use immediately. Do not re-freeze.

2.       For Human Liver Ductal Organoid Expansion Medium. Add 200 μL Human Liver Ductal Organoid Supplement B(50x) (Expansion), 40 μL Human Liver Ductal Organoid Supplement C(250x) (Expansion) to Human Liver Ductal Organoid Basal Medium(Expansion). Mix thoroughly.

NOTE: If not use immediately, store complete medium at 2-8°C for not more than 2 weeks. bioGenousTM Human Liver Ductal Organoid Supplement B (Expansion) contains fungicide and antibiotics(50x).

Protocol for Establishment of Human Liver Ductal Organoids

CAUTIONStudies involving primary human tissue material must follow all relevant institutional and governmental regulations. Informed consent must be obtained from all subjects before the collection of the primary human tissue material.

Establishment of Organoids from Primary Tissue

1.       Collect primary human liver tissue pieces in ice-cold Primary Tissue Storage Solution (K601005) with conical tubes. Keep tissue samples at 4°C until the start of the isolation.

2.       Assess whether the obtained tissue pieces consist purely of epithelium or if they also contain fat or muscle tissue. If so, remove non-epithelial components as much as possible using surgical scissors or scalpels and forceps under a dissection microscope. If no fat or muscle tissue are present, continue to the next step immediately.

3.       Rinse the liver tissue with Epithelial Organoid Basal Medium(B213151) or DPBS until the supernatant is clear.

4.       Before ducts isolation, thaw Matrigel on ice and keep it cold. Add 5 mL of FBS to 45 mL of Epithelial Organoid Basal Medium to prepare 10% (vol/vol) FBS medium.

5.       Mince the tissue into small fragments of 5 mm3 in a cell culture dish using surgical scissors or scalpels.

CRITICAL The dissected samples must be small enough to pass through the tip of a 10 mL pipette.

6.       Place the dissected pieces of sample into a 15 mL conical tube containing 10 mL of cold Epithelial Organoid Basal Medium with 1% FBS.

7.       Wash the samples by pipetting with a 10 mL pipette at least ten times.

CRITICAL For the subsequent steps, coat the inner surface of every 10 mL pipette with 10% (vol/vol) FBS medium before use to avoid adherence of the samples on the pipette wall.

8.       Stand the tube still until the samples settle at the bottom. Aspirate the supernatant with a 10 mL pipette and add 10 mL of pre-warmed Tissue Digestion Solution (K601008).

9.       Digest the tissue fractions in 37 with rotation at the speed of 100 rpm. The digestion time should not exceed 30 mins.

CRITICAL To prevent over-digestion, one should examine under the microscope if the duct structure appear during digestion.

10.    Once the duct structure appears, stop digestion by transfer the digestion solution into 50mL tube and add 40 ml Epithelial Organoid Basal Medium with 1% FBS.

11.    Stand the tube for 2 min. Transfer the supernatant into a new tube.

12.    Spin the supernatant at 4°C at 300g for 3 min. Aspirate and discard the supernatant.

13.    Re-suspend the pellet with 10 ml DMEM with 1%FBS, and spin at 4°C at 300g for 3 min.

14.    Repeat last step for 2 times.

15.    Aspirate the supernatant and resuspend the pellet in Matrigel. Matrigel should be kept on ice to prevent it from solidifying; thus, work quickly. The amount of Matrigel depends on the size of the pellet. Approximately 20-100 ducts should be plated in 25 μL of Matrigel.

CRITICAL Do not dilute Matrigel too much (Matrigel should be >70% (Matrigel vol/Total vol)) to ensure formation of solid droplets.

16.    Plate the Matrigel containing organoids on the bottom of 24-well cell culture plates in droplets of ~30 μL each around the center of the well.

CRITICALOnce the organoids are resuspended in Matrigel, proceed with plating as quickly as possible, as the Matrigel may solidify in the tube or pipette tip. Do not let the Matrigel touch the wall of wells.

17.    Place the culture plate into a humidified incubator at 37 °C and 5% (vol/vol) CO2 for 15-25 min to let the Matrigel solidify.

18.    Prepare the required amount of bioGenousTM Human Liver Ductal Organoid Expansion Medium.

19.    Once the Matrigel droplets are solidified (15-25 min), open the plate and carefully add 500 μL of Organoid Complete Medium to each well.

CRITICAL Do not add the medium directly on top of the Matrigel droplets, as this might disrupt the droplets.

20.    Place the culture plate in a humidified incubator at 37 °C and 5% (vol/vol) CO2.

21.    Change the medium every 3 days by carefully aspirating medium from the wells and replacing it with fresh, pre-warmed Organoid Complete Medium.

22.    Closely monitor the organoid formation. Ideally, human liver ductal organoids should be passaged for the first time between 5 and 8 days after initial plating.

Splitting and Passaging of Organoids

23.    Pipette up and down to disrupt the Matrigel, and transfer the organoid suspension into a 1.5 mL conical tube.

24.    Pipette the organoid suspension up and down to mix thoroughly.Use the bottom of the tube to create pressure, which will aid the removal of Matrigel.

25.    Centrifuge organoids at 200g for 3 min at room temperature.

26.    Aspirate the supernatant, and split organoids using either mechanical disruption or Organoid Dissociation Solution (E238001). For mechanical disruption, resuspend the pellet in 1 mL of Organoid Basal Medium. Use a pipette tip to pipette the organoid suspension up and down 30 times. Use the bottom of the tube to create pressure, which will aid organoid disruption. In case of Organoid Dissociation Solution-based cell dissociation, resuspend the pellet in 0.2 mL of Organoid Dissociation Solution, pipette up and down and incubate at 37 °C until organoids fall apart. Pipette up and down with a filter tip for ≥10 times every 1 min to aid in the disruption of the organoids. Monitor digestion closely to keep the incubation time in Organoid Dissociation Solution to a minimum.

CRITICAL Do not dissociate in Organoid Dissociation Solution for >3 min, as this may result in poor organoid outgrowth or even loss of the culture. As a rule of thumb, digestion is complete if a mixture of small lumps of cells (consisting of 10–50 cells) can be observed.

27.    After shearing is complete, wash once by topping up with 1 mL ofOrganoid Basal Medium, and centrifuge at 200g for 3 min at room temperature.

28.    Aspirate the supernatant and resuspend the organoid pellet in 70% (vol/vol) Matrigel, and plate organoids in droplets on the bottom of a culture plate as described in Steps 12. After plating is complete, transfer the plate into a  humidified incubator at 37 °C and 5% (vol/vol) CO2 for 15–25 min.

29.    Pre-warm Human Liver Ductal Organoid Maintenance Medium at 37 °C.

30.    After the Matrigel droplets have solidified (15–25 min), carefully pipette pre-warmed medium into the wells.

31.    Place culture plates in a humidified incubator at 37 °C and 5% (vol/vol) CO2 until the organoids are needed for further experiments.

bioGenous人胃上皮 Human Gastric Epithelial Organoid Kit(K2004-HG)

人胃上皮 Human Gastric Epithelial Organoid Kit

货号:K2004-HG

规格:100ml

500ml

品牌:bioGenous

产品介绍

Product Description:

bioGenousTM Human Gastric Epithelial Organoid Kit is a chemically defined cell culture medium for establishment and maintenance of human gastric epithelial organoids derived from adult stem cells. Self-renewal of the gastric epithelium is driven by the proliferation of stem cells and their progenitors. Human gastric epithelial organoids display all hallmarks of the gastric epithelium in terms of architecture, cell type composition, and self-renewal dynamics, therefore hold great promise for unprecedented studies of human gastric epithelial homeostasis and disease.


技术参数

Product Information:

Component

Component Cat#

Volume

Storage& Stability

bioGenousTM Human Gastric Epithelial Organoid Basal Medium

K2004-HG-A100/A500

100 mL/500 mL

412 months

bioGenousTM Human Gastric Epithelial Organoid Supplement B(50x)

K2004-HG-B100/B500

2 mL/10 mL

-20,avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Gastric Epithelial Organoid Supplement C(250x)

K2004-HG-C100/C500

0.4 mL/2 mL

-20, avoid repeated freeze-thaw cycles, 12 months

bioGenousTM Human Gastric Epithelial Organoid Supplement D(250x)

K2004-HG-D100/D500

0.4 mL/2 mL

-20, avoid repeated freeze-thaw cycles, 12 months

Preparation of Human Gastric Epithelial Organoid Primary Culture Medium and Maintenance Medium

Use sterile technique to prepare the Human Gastric Epithelial Organoid Primary Culture Medium and Maintenance Medium. Gastric epithelial organoids grown in Human Gastric Epithelial Organoid Maintenance Medium contain LGR5+ stem cells, pit mucous cells, gland mucous cells, chief cells, as well as a low number of enteroendocrine cells. The following examples are for preparing 10 mL of Primary Culture Medium and Maintenance Medium. If preparing other volumes, adjust accordingly.

1.      Thaw Human Gastric Epithelial Organoid Supplement B(50x), Human Gastric Epithelial Organoid Supplement C(250x) and Human Gastric Epithelial Organoid Supplement D(250x) on ice. Mix thoroughly.

NOTE: Once thawed, use immediately or aliquot and store at -20°C for not more than 10 months. After thawing the aliquots, use immediately. Do not re-freeze.

2.      For Human Gastric Epithelial Organoid Primary Culture Medium which used specifically for primary culture and resuscitation. Add 200 μL Human Gastric Epithelial Organoid Supplement B(50x), 40 μL Human Gastric Epithelial Organoid Supplement C(250x) and 40 μL Human Gastric Epithelial Organoid Supplement D(250x) to 9.72 mL Human Gastric Epithelial Organoid Basal Medium. Mix thoroughly.

3.      For Human Gastric Epithelial Organoid Maintenance Medium which used specifically for long-term culture. Add 200 μL Human Gastric Epithelial Organoid Supplement B(50x) and 40 μL Human Gastric Epithelial Organoid Supplement C(250x) to 9.76 mL Human Gastric Epithelial Organoid Basal Medium. Mix thoroughly.

NOTE: If not use immediately, store complete medium at 2-8°C for not more than 2 weeks. bioGenousTM Human Gastric Epithelial Organoid Supplement B contains fungicide and antibiotics(50x).

Protocol for Establishment of Human Gastric Epithelial Organoids

CAUTIONStudies involving primary human tissue material must follow all relevant institutional and governmental regulations. Informed consent must be obtained from all subjects before the collection of the primary human tissue material.

Establishment of Organoids from Primary Tissue

1.      Collect 1-2 cm2 primary human gastric tissue pieces in ice-cold Primary Tissue Storage Solution (K601005) with conical tubes. Keep tissue samples at 4°C until the start of the isolation.

2.      Assess whether the obtained tissue pieces consist purely of epithelium or if they also contain fat or muscle tissue. If so, remove non-epithelial components as much as possible using surgical scissors or scalpels and forceps under a dissection microscope. If no fat or muscle tissue are present, continue to the next step immediately.

3.      Rinse the gastric tissue with Epithelial Organoid Basal Medium(B213151) or DPBS until the supernatant is clear.

4.      Before glands isolation, thaw Matrigel on ice and keep it cold. Add 5 mL of FBS to 45 mL of Epithelial Organoid Basal Medium to prepare 10% (vol/vol) FBS medium.

5.      Mince the tissue into small fragments of 5 mm3 in a cell culture dish using surgical scissors or scalpels.

CRITICAL The dissected samples must be small enough to pass through the tip of a 10 mL pipette.

6.      Place the dissected pieces of sample into a 15 mL conical tube containing 10 mL of cold DPBS.

7.      Wash the samples by pipetting with a 10 mL pipette at least ten times.

CRITICAL For the subsequent steps, coat the inner surface of every 10 mL pipette with 10% (vol/vol) FBS medium before use to avoid adherence of the samples on the pipette wall.

8.      Stand the tube still until the samples settle at the bottom. Aspirate the supernatant with a 10 mL pipette and add 10 mL of cold DPBS.

9.      Repeat Steps 7 and 8 3–5 times until the supernatant is free of debris.

CRITICAL Thorough washing of the sample is crucial to avoid bacterial contamination.

10.   Add 10 mL of cold DPBS supplemented with 2 mM EDTA (E219121) to the tube. Place the tube on a rocking shaker and rock it gently at 4 °C for 40 min.

11.   After treatment with EDTA, stand the tube still until the samples settle to the bottom of the tube, and then aspirate the supernatant with a 10 mL pipette and add 10 mL of cold DPBS.

12.   Stand the tube still until the samples settle at the bottom. Aspirate the supernatant with a 10 mL pipette.

13.   Add 10 mL of cold DPBS and pipette up and down at least ten times with a 10 mL pipette. Allowed the tissue fragments to settle down under normal gravity for at least 30s. The glands will be released into the supernatant by pipetting. Place the supernatant containing the isolated glands into a new 15 mL tube.

14.   Spin the glands at 4°C at 300g for 3 min. Remove the supernatant and place the tube on ice.

15.   Resuspend the pellet in 1 mL of DPBS and transfer the glands suspension into a new 1.5 mL tube. Drop 20 μL of the gland suspension on a petri dish. Count the number of glands under a stereomicroscope and calculate the total number of glands.

16.   Spin the glands at 4°C at 300g for 3 min. Aspirate and discard the supernatant.

17.   Aspirate the supernatant and resuspend the pellet in Matrigel. Matrigel should be kept on ice to prevent it from solidifying; thus, work quickly. The amount of Matrigel depends on the size of the pellet. Approximately 100-250 glands should be plated in 25 μL of Matrigel.

CRITICAL Do not dilute Matrigel too much (Matrigel should be >70% (Matrigel vol/Total vol)) to ensure formation of solid droplets.

18.   Plate the Matrigel containing organoids on the bottom of 24-well cell culture plates in droplets of 25 μL each around the center of the well.

CRITICALOnce the organoids are resuspended in Matrigel, proceed with plating as quickly as possible, as the Matrigel may solidify in the tube or pipette tip. Do not let the Matrigel touch the wall of wells.

19.   Place the culture plate into a humidified incubator at 37 °C and 5% (vol/vol) CO2 for 15-25 min to let the Matrigel solidify.

20.   Prepare the required amount of Human Gastric Epithelial Organoid Primary Culture Medium.

21.   Once the Matrigel droplets are solidified (15-25 min), open the plate and carefully add 500 μL of Human Gastric Epithelial Organoid Primary Culture Medium to each well.

CRITICAL Do not add the medium directly on top of the Matrigel droplets, as this might disrupt the droplets.

22.   Place the culture plate in a humidified incubator at 37 °C and 5% (vol/vol) CO2.

23.   Change the medium every 3 days by carefully aspirating medium from the wells and replacing it with fresh, pre-warmed medium.

24.   Closely monitor the organoid formation. Ideally, human gastric epithelial organoids should be passaged for the first time between 5 and 8 days after initial plating.

Splitting and Passaging of Organoids

1.      Pipette up and down to disrupt the Matrigel, and transfer the organoid suspension into a 1.5 mL conical tube.

2.      Pipette the organoid suspension up and down to mix thoroughly.Use the bottom of the tube to create pressure, which will aid the removal of Matrigel.

3.      Centrifuge organoids at 300g for 3 min at room temperature.

4.      Aspirate the supernatant, and split organoids using either mechanical disruption or Organoid Dissociation Solution (E238001). For mechanical disruption, resuspend the pellet in 1 mL of Organoid Basal Medium. Use a pipette tip to pipette the organoid suspension up and down 30 times. Use the bottom of the tube to create pressure, which will aid organoid disruption. In case of Organoid Dissociation Solution-based cell dissociation, resuspend the pellet in 0.2 mL of Organoid Dissociation Solution, pipette up and down and incubate at 37 °C until organoids fall apart. Pipette up and down with a filter tip for ≥10 times every 1 min to aid in the disruption of the organoids. Monitor digestion closely to keep the incubation time in Organoid Dissociation Solution to a minimum.

CRITICAL Do not dissociate in Organoid Dissociation Solution for >3 min, as this may result in poor organoid outgrowth or even loss of the culture. As a rule of thumb, digestion is complete if a mixture of small lumps of cells (consisting of 10–50 cells) can be observed.

5.      After shearing is complete, wash once by topping up with 1 mL ofOrganoid Basal Medium, and centrifuge at 300g for 3 min at room temperature.

6.      Aspirate the supernatant and resuspend the organoid pellet in 70% (vol/vol) Matrigel, and plate organoids in droplets on the bottom of a culture plate as described in Steps 17. After plating is complete, transfer the plate into a humidified incubator at 37 °C and 5% (vol/vol) CO2 for 15–25 min.

7.      Pre-warm Human Gastric Epithelial Organoid Maintenance Medium at 37 °C.

8.      After the Matrigel droplets have solidified (15–25 min), carefully pipette pre-warmed medium into the wells.

9.      Place culture plates in a humidified incubator at 37 °C and 5% (vol/vol) CO2 until the organoids are needed for further experiments.